Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

SELL
$38.25 - $52.62 $431,154 - $593,132
-11,272 Reduced 64.72%
6,145 $240,000
Q2 2022

Aug 12, 2022

SELL
$35.1 - $66.01 $167,356 - $314,735
-4,768 Reduced 21.49%
17,417 $712,000
Q1 2022

May 11, 2022

SELL
$57.43 - $71.39 $22,340 - $27,770
-389 Reduced 1.72%
22,185 $1.46 Million
Q4 2021

Feb 08, 2022

SELL
$63.4 - $87.14 $139,289 - $191,446
-2,197 Reduced 8.87%
22,574 $1.57 Million
Q3 2021

Nov 02, 2021

BUY
$69.28 - $84.46 $97,061 - $118,328
1,401 Added 5.99%
24,771 $1.72 Million
Q2 2021

Aug 11, 2021

BUY
$64.13 - $80.18 $359,256 - $449,168
5,602 Added 31.53%
23,370 $1.85 Million
Q1 2021

May 14, 2021

BUY
$53.79 - $66.98 $123,609 - $153,920
2,298 Added 14.85%
17,768 $1.16 Million
Q4 2020

Feb 12, 2021

BUY
$34.56 - $57.55 $232,727 - $387,541
6,734 Added 77.08%
15,470 $861,000
Q3 2020

Nov 04, 2020

BUY
$38.36 - $46.91 $335,112 - $409,805
8,736 New
8,736 $349,000
Q3 2017

Nov 13, 2017

SELL
$20.0 - $24.23 $600,000 - $726,900
-30,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
30,000
30,000 $728,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.67B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.